F. Hoffmann-La Roche Ltd (manufacturing unpackaged products, quality control testing, batch release, primary and secondary packaging)

The drug is used for the prevention of bone damage (pathological fractures and lesions requiring surgery or radiotherapy) in patients with breast cancer and bone metastases.

Dosage form: tablets, film-coated

ATC: M05BA06